The acne treatment market is expanding steadily as the prevalence of acne remains high across adolescent and adult populations worldwide. Treatment options range from over-the-counter topical creams and cleansers to prescription medications like retinoids, antibiotics, hormonal therapies, and innovative procedures (such as chemical peels, laser therapy, and phototherapy). Key market drivers include increasing skincare awareness, growing interest in aesthetic wellness, and advances in product formulation and delivery systems. With rising focus on personalized skincare regimens, clean beauty, and minimally invasive procedures, the acne treatment market continues to evolve, offering a diverse range of solutions that cater to different skin types and severity levels.
According to Fortune Business Insights, the global acne treatment market was valued at USD 11.62 billion in 2024. The market is projected to grow from USD 12.19 billion in 2025 to USD 17.48 billion by 2032, exhibiting a CAGR of 5.3% during the forecast period. In 2023, North America dominated the acne treatment market with a market share of 49.14%.
In October 2023, tbh Skincare inked a deal with Coles, one of Australia’s largest supermarket chains, to distribute its acne treatment products across 857 stores. This move enhances product accessibility and taps into the booming retail wellness sector.